Future studies should be conducted for repurposing sustained augmentation of IGF-1 with the supplement in weight control, and to assess its benefits in otherwise healthy individuals with obesity and low-normal hGH. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.